Health agencies of Mexico, Spain, Colombia, Paraguay and Central America, signed a letter of intent (LOI) aiming to strengthen joint surveillance on the sale of medicines over the Internet and reduce health risk.
Health agencies agreed to create a regional observatory (Observatorio Regional) to monitor Internet medicine sales and to establish legal mechanisms to fight misleading advertising. The efforts will also include education of the public on the risks of consuming drugs that have no scientific backing.
Mexican health agency (COFEPRIS) representatives highlighted that this regional resolution to fight misleading advertising can help protect the health of 230 million consumers in the signatory countries. This strategic agreement aims to strengthen the regulation and control of drugs offered through the Internet, which often offer misleading claims and are often without health registration.
Representatives of COFEPRIS also stressed that misleading advertising in the Internet has been fought hard with effective watches and agreements with companies such as eBay, and with the support of the local Cyber Police (Policía de Ciberdelincuencia Preventiva). During the period of 2013 to 2015, 10,311 illegal advertisements were suspended, representing an increase of 329 percent over 2012.
The Pan American Health Organization (PAHO) together with Health Canada hold the VII Conference of the Pan American Network for Drug Regulatory Harmonization (CPANDRH), in Ottawa, Canada from September 5th-7th, 2013. This year’s theme was “Sixteen years promoting Good Regulatory Practices in the Region of the Americas”.
Among the key issues discussed at this conference is the PANDRH Strategic Development Plan 2014-2020, which aim to:
• Promote efficient governance of the network, active participation and cooperation of National Regulatory Authorities (NRAs);
• Establish priorities for regulatory harmonization and support their dissemination, adoption and implementation;
• Promote strengthening of Good Regulatory Practices; and
• Promote exchanges of experiences and lessons learned between NRAs of the Americas and NRAs of other regions.
This Conference is held every two or three years. Its mission is “to promote drug regulatory harmonization for all aspects of quality, safety, and efficacy of pharmaceutical products as a contribution to the quality of life and health care of the citizens of the Member Countries of the Americas”.
This Conference was coordinated by PAHO, with the collaboration and financial support of the Regulatory Authority of Canada (Health Canada).
Manufacturers of healthcare products, mainly those located outside Latin America often doubt about how their products will be considered in this region. This question is also frequently asked by manufacturers of medical devices, especially by the time a regional business strategy is being discussed.
We kindly invite you to read our article that highlights some actions that will give an answer to this question. Download the complete version from the articles’ section of Regulatory Affairs at www.moellerip.com or request it at email@example.com